Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 03, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- June 23, 2006: Transfer of 15,458 Ordinary Shares.
- June 29, 2006: Transfer of 20,525 Ordinary Shares.
The Company was advised of these transactions on June 30, 2006. The GSK Trust is a discretionary trust for current and former employees. Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (35,983 shares).
- Confirm the identity of the directors with interests in the GSK Trust: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop.
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for financial metrics.